Danielle Pineda, MD
Vascular Surgery · Pomona, NJNPI 1447417522
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $65,166 of the $96,677 with a category attached, or 67.4%. Medtronic accounts for 87.7% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $30,041, 9.7 times the $3,097 reported in 2019. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 342 payments — averaging $282.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$85K
- W. L. Gore & Associates, Inc.$3K
- Cook Medical LLC$2K
- Cook Incorporated$2K
- Endologix LLC$708
- Boston Scientific$705
- plus $3K from 31 others
What the payments were for
- Speaking & faculty fees$65,16667%
- Grants$670%
- Travel & lodging$16,17417%
- Food & beverage$15,27016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 172 | $84,826 |
| W. L. Gore & Associates, Inc. | 29 | $3,216 |
| Cook Medical LLC | 35 | $2,334 |
| Cook Incorporated | 1 | $2,000 |
| Endologix LLC | 8 | $708 |
| Boston Scientific | 13 | $705 |
| Johnson & Johnson(2 entities) | 18 | $401 |
| Smith+Nephew | 7 | $291 |
| Silk Road Medical, Inc. | 4 | $269 |
| Inari Medical, Inc. | 3 | $264 |
| Shockwave Medical, Inc | 4 | $253 |
| Baxter Healthcare | 5 | $175 |
| Cagent Vascular Inc | 1 | $127 |
| Getinge USA Sales, LLC | 2 | $112 |
| Sanara Medtech Inc. | 2 | $102 |
| Abbott | 1 | $97 |
| Lemaitre Vascular, Inc. | 7 | $95 |
| Penumbra, Inc. | 1 | $65 |
| Tactile Systems Technology Inc | 3 | $61 |
| Bolton Medical Inc | 2 | $61 |
| Angiodynamics, Inc. | 2 | $58 |
| Hartmann USA, Inc. | 2 | $57 |
| Cvrx, Inc. | 2 | $56 |
| Acera Surgical, Inc. | 2 | $51 |
| Terumo Medical Corporation | 4 | $49 |
| Stryker | 1 | $36 |
| Covidien LP | 1 | $25 |
| Surmodics, Inc. | 1 | $24 |
| Biocompatibles, Inc. | 1 | $24 |
| Sirtex Medical Inc | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Mannkind Corporation | 1 | $19 |
| Mimedx Group, Inc. | 1 | $17 |
| Davol Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $14 |
| Avenu Medical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$75,737
- NA$2,658
- Zenith Alpha$2,000
- Valiant Navion$1,726
- GORE VIABAHN VBX Balloon Expandable Endo$1,719
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$648
- Zenith Spiral-Z$467
- GORE VIABAHN Endoprosthesis with Heparin$379
- Zenith$365
- HawkOne$327
- Alto Abdominal Stent Graft System$320
- ENROUTE Transcarotid Neuroprotection System$282
- Endurant$277
- Ovation$202
- AFX$202
- FLOWTRIEVER CATHETER, S$198
- CT THROMBECTOMY SYSTEM KIT$198
- Ranger$169
- Heli-FX EndoAnchor System$166
- ENROUTE Transcarotid Stent$150
How this compares
$96,677 in reported general payments places this provider in the 95th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $27,700 |
| XareltoRivaroxaban | 31 | $25,139 |
| ClopidogrelClopidogrel Bisulfate | 129 | $1,706 |
| Cilostazol | 46 | $753 |
| Gabapentin | 21 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $27,70021 claims |
| Johnson & JohnsonXarelto | $401 | $25,13931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Pomona
- Joseph LombardiPomona$266K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Saum RahimiNew Brunswick$90K
- Michael LiebHainesport$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.